Header Logo

Connection

MEGAN WANG to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications MEGAN WANG has written about Drug Resistance, Neoplasm.
MEGAN WANG
Connection Strength
0.158
Drug Resistance, Neoplasm
  1. Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatment. Future Oncol. 2024 Apr; 20(12):717-726.
    View in: PubMed
    Score: 0.158
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.